<?xml version="1.0" encoding="UTF-8"?><html xmlns="http://www.w3.org/1999/xhtml" xmlns:oboInOwl="http://www.geneontology.org/formats/oboInOwl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:obo="http://purl.obolibrary.org/obo/" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:xsd="http://www.w3.org/2001/XMLSchema#" xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#" xmlns:dublincorens="http://purl.org/dc/elements/1.1/"  version="XHTML+RDFa 1.0" ><body>Knockdown Asparagine Synthetase Renders <br /> Trypanosoma brucei Auxotrophic Asparagine <br /> Ine&#203;&#8224;s Loureiro1, Joana Faria1, Christine Clayton2, Sandra Macedo Ribeiro3, Nilanjan Roy4, <br /> Nuno Santare&#194;&#180;m1, Joana Tavares1.*, Anabela Cordeiro-da-Silva1,5.* <br /> 1 Parasite Disease Group, Instituto Biologia Molecular e Celular da Universidade Porto, Porto, Portugal, 2 Zentrum fu&#194;&#168;r Molekulare Biologie der Universita&#194;&#168;t <br /> Heidelberg, DKFZ-ZMBH Alliance, Heidelberg, Germany, 3 Protein Crystallography Group, Instituto Biologia Molecular e Celular da Universidade Porto, Porto, <br /> Portugal, 4 Ashok Rita Patel Institute Integrated Study Research Biotechnology Allied Sciences, New Vallabh Vidyanagar, Gujarat, India, 5 Departamento Cie&#203;&#8224;ncias Biolo&#194;&#180;gicas, Faculdade Farma&#194;&#180;cia da Universidade Porto, Porto, Portugal <br />  <br />  <br />  <br />        Abstract <br />        Asparagine synthetase   catalyzes <span id='am-38' about='obo:IMR_0001351' typeof='owl:Thing obo:IMR_0000967 obo:IMR_0001657 obo:IMR_0000947 obo:IMR_0000965 obo:IMR_0001349 obo:IMR_0000001 obo:IMR_0001698'><span id='am-39' property="oboInOwl:hasDbXref" content="KEGG:C00002" datatype="xsd:string"></span><span id='am-40' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-41' property="rdfs:label" content="adenosine triphosphate" datatype="xsd:string"></span><span id='am-42' property="rdfs:label" content="ATP" datatype="xsd:string"></span><span id='am-43' property="rdfs:label" content="adenosine 5&apos;-triphosphate" datatype="xsd:string"></span><span id='am-44' property="oboInOwl:hasExactSynonym" content="adenosine 5&apos;-triphosphate" datatype="xsd:string"></span><span id='am-45' property="oboInOwl:id" content="IMR:0001351" datatype="xsd:string"></span><span id='am-46' property="oboInOwl:hasAlternativeId" content="IMR:0200394" datatype="xsd:string"></span><span id='am-47' property="oboInOwl:hasExactSynonym" content="adenosine triphosphate" datatype="xsd:string"></span><span id='am-48' property="oboInOwl:hasAlternativeId" content="IMR:0100127" datatype="xsd:string"></span>ATP</span>-dependent conversion aspartate asparagine using ammonia        glutamine nitrogen source. distinct types  asparagine synthetase  , known strictly <br />        ammonia-dependent, asparagine synthetase B  B), use ammonia glutamine. absence  <br />        humans, presence trypanosomes, suggested potential drug target deserved        investigation. report presence functional Trypanosoma cruzi (TcAS  Trypanosoma brucei (TbAS : <br />        purified enzymes convert L-aspartate <span id='am-89' about='obo:IMR_0200113' typeof='owl:Thing obo:IMR_0000947 obo:IMR_0001695 obo:IMR_0000001'><span id='am-90' property="rdfs:label" content="L-Asparagine" datatype="xsd:string"></span><span id='am-91' property="oboInOwl:id" content="IMR:0200113" datatype="xsd:string"></span><span id='am-92' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-93' property="oboInOwl:hasDbXref" content="KEGG:C00152" datatype="xsd:string"></span>L-asparagine</span> presence ATP, ammonia Mg2+. TcAS TbAS        use preferentially ammonia nitrogen donor, surprisingly, use glutamine, characteristic far        described  TbAS knockdown RNAi didn&#226;&#8364;&#8482;t affect vitro growth bloodstream forms parasite. <br />         growth significantly impaired TbAS knockdown parasites cultured medium reduced <br />        levels asparagine. expected, mice infections induced non-induced T. brucei RNAi clones similar        wild-type parasites.  induced T. brucei RNAi clones injected mice undergoing asparaginase <br />        treatment, depletes blood asparagine, mice exhibited lower parasitemia prolonged survival comparison <br />        similarly-treated mice infected control parasites. results TbAS important vivo <br />        conditions asparagine limiting, unlikely suitable drug target. <br />  <br />      Citation: Loureiro  Faria J, Clayton C, Ribeiro SM, Roy N, et al. (2013) Knockdown Asparagine Synthetase Renders Trypanosoma brucei Auxotrophic      Asparagine. PLoS Negl Trop Dis 7(12): e2578. doi:10.1371/journal.pntd.0002578 <br />      Editor: Alejandro Buschiazzo, Institut Pasteur Montevideo, Uruguay <br />      Received August 1, 2013; Accepted October 25, 2013; Published December 5, 2013 <br />      Copyright: &#195;&#376; 2013 Loureiro et al. open-access article distributed terms Creative Commons Attribution License, permits <br />      unrestricted use, distribution, reproduction medium, provided original author source credited. <br />      Funding: authors received specific funding study. <br />      Competing Interests: authors declared competing interests exist. <br />      * E-mail: jtavares@ibmc pt (JT); cordeiro@ibmc pt (ACdS) <br />      . authors contributed equally work. <br />  <br />  <br />  <br />  <br /> Introduction                                                                              AS-B share sequence structural similarities. <br />                                                                                        dimensional structures provided important informa- <br />    Asparagine naturally occurring non-essential <span id='am-57' about='obo:IMR_0001695' typeof='owl:Thing obo:IMR_0000947 obo:IMR_0000001'><span id='am-58' property="oboInOwl:hasDbXref" content="MeSH:D000596" datatype="xsd:string"></span><span id='am-59' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-60' property="obo:IAO_0000115" content="Organic compounds that generally contain an amino (-NH2) and a carboxyl (-COOH) group. Twenty alpha-amino acids are the subunits which are polymerized to form proteins." datatype="xsd:string"></span><span id='am-61' property="rdfs:label" content="amino acid" datatype="xsd:string"></span><span id='am-62' property="oboInOwl:id" content="IMR:0001695" datatype="xsd:string"></span><span id='am-63' property="oboInOwl:hasDbXref" content="CHEBI:33709" datatype="xsd:string"></span>amino acid</span>                        tion concerning distinct catalytic mechanisms [2,23&#226;&#8364;&#8220;25].  proteins. high nitrogen/carbon ratio,                         exists dimer monomer core b- <br /> asparagine likely linked nitrogen homeostasis                          strands flanked helices, resembling catalytic domain protein biosynthesis [1]. protein involved asparagine                     class II aminoacyl-tRNA synthetases aspartyl-tRNA <br /> biosynthesis. distinct types  AS-B,                       synthetase [24]. synthesizes asparagine steps: b- <br /> encoded asnA asnB genes, respectively. encoding                            carboxylate group aspartate activated ATP form genes reported archaea [2,3], prokaryotes [4&#226;&#8364;&#8220;7],                      aminoacyl-<span id='am-16' about='obo:IMR_0200083' typeof='owl:Thing obo:IMR_0001657 obo:IMR_0000947 obo:IMR_0001349 obo:IMR_0000001 obo:IMR_0001698'><span id='am-17' property="rdfs:label" content="Adenosine 5&apos;-monophosphate" datatype="xsd:string"></span><span id='am-18' property="oboInOwl:hasExactSynonym" content="Adenosine 5&apos;-monophosphate" datatype="xsd:string"></span><span id='am-19' property="oboInOwl:hasDbXref" content="KEGG:C00020" datatype="xsd:string"></span><span id='am-20' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-21' property="oboInOwl:id" content="IMR:0200083" datatype="xsd:string"></span><span id='am-22' property="rdfs:label" content="AMP" datatype="xsd:string"></span>AMP</span>, followed amidation nucleophilic attack protozoan parasite Leishmania [8]. B encoding gene                       ammonium <span id='am-10' about='obo:IMR_0001658' typeof='owl:Thing obo:IMR_0000947 obo:IMR_0000001'><span id='am-11' property="oboInOwl:id" content="IMR:0001658" datatype="xsd:string"></span><span id='am-12' property="oboInOwl:hasDbXref" content="CHEBI:24870" datatype="xsd:string"></span><span id='am-13' property="obo:IAO_0000115" content="An atom that has either gained or lost electrons to acquire a chage; for example Na+ and Cl-." datatype="xsd:string"></span><span id='am-14' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-15' property="rdfs:label" content="ion" datatype="xsd:string"></span>ion</span> [2]. B enzyme forms dimer, present prokaryotes [5,9] eukaryotes, including                      monomer contains distinct domains, mammalian cells [10,11], yeasts [12], algae [13], higher plants                    contains catalytic site. N-terminal site catalyzes [14]. types catalyze ATP-dependent conversion                              conversion glutamine <span id='am-64' about='obo:IMR_0100119' typeof='owl:Thing obo:IMR_0000967 obo:IMR_0000947 obo:IMR_0000965 obo:IMR_0001695 obo:IMR_0000001 obo:IMR_0100116'><span id='am-65' property="oboInOwl:id" content="IMR:0100119" datatype="xsd:string"></span><span id='am-66' property="rdfs:label" content="L-Glutaminic acid" datatype="xsd:string"></span><span id='am-67' property="oboInOwl:hasDbXref" content="KEGG:C00025" datatype="xsd:string"></span><span id='am-68' property="oboInOwl:hasExactSynonym" content="L-Glutamic acid" datatype="xsd:string"></span><span id='am-69' property="oboInOwl:hasExactSynonym" content="L-Glutaminic acid" datatype="xsd:string"></span><span id='am-70' property="oboInOwl:hasAlternativeId" content="IMR:0200156" datatype="xsd:string"></span><span id='am-71' property="oboInOwl:hasExactSynonym" content="L-Glutamate" datatype="xsd:string"></span><span id='am-72' property="rdfs:label" content="L-Glutamic acid" datatype="xsd:string"></span><span id='am-73' property="rdfs:label" content="glutamic acid" datatype="xsd:string"></span><span id='am-74' property="rdfs:label" content="L-Glutamate" datatype="xsd:string"></span><span id='am-75' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span>glutamic acid</span> ammonia, aspartate asparagine. B use ammonia                             aspartate reacts ATP C-terminal site, generating glutamine (reaction B) amide nitrogen donors [5,15&#226;&#8364;&#8220;20],                         intermediate b-aspartyl-AMP [26,27]. Similarly gluta- <br /> Escherichia coli (E. coli) reported dependent strictly                  dependent amidotransferases, ammonia released N- ammonia (reaction  [21,22].                                                       terminal domain enzyme travels intramolecular <br />                                                                                        tunnel connecting active sites, reacts reactive       ATP + L-aspartate + NH4+ = . AMP + diphosphate + L-                            acyladenylate intermediate produce asparagine [28]. <br />         asparagine                                                                        open reading frame encoding putative present B)      ATP + L-aspartate + <span id='am-33' about='obo:IMR_0200448' typeof='owl:Thing obo:IMR_0000947 obo:IMR_0001695 obo:IMR_0000001'><span id='am-34' property="oboInOwl:hasDbXref" content="KEGG:C00064" datatype="xsd:string"></span><span id='am-35' property="oboInOwl:id" content="IMR:0200448" datatype="xsd:string"></span><span id='am-36' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-37' property="rdfs:label" content="L-Glutamine" datatype="xsd:string"></span>L-glutamine</span>  NH4+] = . AMP +                            genome protozoan parasites, Trypanosoma cruzi (T. cruzi) <br />         diphosphate + L-asparagine + <span id='am-76' about='obo:IMR_0100119' typeof='owl:Thing obo:IMR_0000967 obo:IMR_0000947 obo:IMR_0000965 obo:IMR_0001695 obo:IMR_0000001 obo:IMR_0100116'><span id='am-77' property="oboInOwl:id" content="IMR:0100119" datatype="xsd:string"></span><span id='am-78' property="oboInOwl:hasDbXref" content="KEGG:C00025" datatype="xsd:string"></span><span id='am-79' property="oboInOwl:hasExactSynonym" content="L-Glutamate" datatype="xsd:string"></span><span id='am-80' property="rdfs:label" content="L-Glutamate" datatype="xsd:string"></span><span id='am-81' property="rdfs:label" content="glutamic acid" datatype="xsd:string"></span><span id='am-82' property="oboInOwl:hasExactSynonym" content="L-Glutaminic acid" datatype="xsd:string"></span><span id='am-83' property="oboInOwl:hasExactSynonym" content="L-Glutamic acid" datatype="xsd:string"></span><span id='am-84' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-85' property="rdfs:label" content="L-Glutaminic acid" datatype="xsd:string"></span><span id='am-86' property="oboInOwl:hasAlternativeId" content="IMR:0200156" datatype="xsd:string"></span><span id='am-87' property="rdfs:label" content="L-Glutamic acid" datatype="xsd:string"></span>L-glutamate</span>                                       Trypanosoma brucei (T. brucei) [29&#226;&#8364;&#8220;31]. T. cruzi T. brucei  <br />  <br /> PLOS Neglected Tropical Diseases | www.plosntds.org                                1                           December 2013 | Volume 7 | Issue 12 | e2578 <br />                                                                                                         Trypanosoma Asparagine Synthetase  <br />  <br />  <br />   Author Summary                                                         Cloning T. brucei T. cruzi ASA genes <br />                                                                             T. brucei asparagine synthetase (TbASA) T. cruzi <br />   amino acid asparagine important                    asparagine synthetase (TcASA) genes obtained performing <br />   protein biosynthesis, nitrogen homeostasis.               PCR genomic DNA Trypanosoma brucei brucei TREU927 <br />   Asparagine synthetase catalyzes synthesis                  Trypanosoma cruzi CL Brener Non-Esmeraldo-like. Fragments <br />   amino acid. forms asparagine synthetase,              open reading frames TbASA (Tb927.7.1110; chromosome <br />   B. presence type trypanosomes,               Tb927_07_v4; 28861 289067) TcASA (Tc00.1047053503 <br />   absence humans, makes protein potential drug <br />                                                                          625.10; chromosome TcChr29-P; 687159&#226;&#8364;&#8220;688206) PCR- <br />   target. Trypanosomes responsible parasitic <br />                                                                          amplified using Taq DNA polymerase proofreading activity <br />   diseases rely limited drug therapeutic options   control. study present functional characteriza-            (Roche). sequences primers follows: sense <br />   tion trypanosomes asparagine synthetase                        primer 59 - CTAATTACATATGGGCGACGACGGTTATTC - <br />   Trypanosoma brucei Trypanosoma cruzi                 39 antisense primer 59 - CCCAAGCGAATTCTTACAACA- <br />   type enzymes able use ammonia                       AATTGTGC - 39, sense primer 59 - CAAT TTGCATATGACA- <br />   glutamine nitrogen donor, conversion                TCGGGAGATCC - 39 antisense primer 59 - CCCAAGCA- <br />   aspartate asparagine. Furthermore,                   AGCTTTCACAGCAAGGG - 39, respectively. PCR conditions <br />   asparagine synthetase knockdown renders Trypanosoma                  follows: initial denaturation (2 min 94uC), 35 cycles   brucei auxotrophic asparagine. Overall, study                  denaturation (30 s 94uC), annealing (30 s 45uC)   demonstrates interfering asparagine metabolism               elongation (2 min 68uC) TbAS  annealing (30 s   represents way control parasite growth infectivity.           50uC) elongation (2 min 68uC) TcAS  final <br />                                                                          extension step (10 min 68uC). PCR products isolated <br />                                                                          1% agarose gel, purified Qiaex II protocol (Qiagen), <br /> transmitted mammalian host invertebrate vector,          cloned pGEM-T Easy vector (Promega) sent responsible Chagas disease African sleeping              Eurofins MWG (Germany) sequencing. <br /> sickness, respectively. Disease control dependent drug <br /> therapy, treatment options limited, high toxicity        Expression purification poly tagged recent emergence drug resistance [32&#226;&#8364;&#8220;34]. Vaccines T.         recombinant TbAS TcAS brucei infections unlikely developed          TbASA TcASA genes subcloned pET28a(+) <br /> extensive antigenic variation [35], infections          expression vector (Novagen). recombinant 6 tagged <br /> compromise host humoral immune competence [36].                          proteins expressed E. coli BL21DE3 induction log- <br />    Trypanosome drug target absence            phase cultures 0.5 mM IPTG (NZYTech) 3 h 37uC homologue humans [8]. important                 (TcAS  18uC, overnight (O/N) (TbAS . Bacteria microorganisms. example, asnA essential gene                harvested resuspended buffer [0.5 M NaCl (Sigma), <br /> Haemophilus influenzae (DEG10050178) [37], strongly            20 mM Tris.HCl (Sigma), pH 7.6]. sample sonicated regulated Pasteurella multocida host infection [38],       centrifuged obtain bacterial crude extract. recombinant Klebsiella aerogenes grown amino acid-limited          proteins purified using Ni2+ resin (ProBond) washing ammonia rich environment [5]. undertook bio-                elution increasing levels (25 mM 1 M) imidazole <br /> <span id='am-1' about='obo:IMR_0000947' typeof='owl:Thing obo:IMR_0000001'><span id='am-2' property="rdfs:label" content="chemical" datatype="xsd:string"></span><span id='am-3' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-4' property="oboInOwl:id" content="IMR:0000947" datatype="xsd:string"></span>chemical</span> genetic studies trypanosomes ascertain        (Sigma). presence purity recombinant protein biological role evaluate potentiality drug target.        fractions determined SDS-PAGE                                                                          Coomassie staining. Dialysis performed PBS <br /> Materials Methods                                                    [137 mM NaCl (Sigma), 2.7 mM KCl (Sigma), 10 mM Na2H- <br />                                                                          PO4.2H2O (Riedel Hae&#194;&#168;n), 2 mM KH2PO4 (Riedel Hae&#194;&#168;n) <br /> Ethics statement                                                         pH 7.4]. <br />   experiments involving animals carried accor-              generate rat rabbit polyclonal antibodies TbAS- <br /> dance IBMC.INEB Animal Ethics Committees                 animal immunized 150 mg recombinant <br /> Portuguese National Authorities Animal Health guidelines,            TbAS protein. 2 weeks, 4 boosts 100 mg according statements directive 2010/63/EU           recombinant TbAS given weekly. collected blood <br /> European Parliament Council.  JT ACS           samples centrifuged obtain serum. <br /> accreditation animal research given Portuguese <br /> Veterinary Direction (Ministerial Directive 1005/92).                    Protein extracts western blot analysis <br />                                                                             Extracts obtained RIPA buffer [(20 mM Tris-HCl <br /> Parasite culture                                                         (Sigma) (pH 7.5), 150 mM NaCl (Sigma), 1 mM Na2EDTA <br />    Procyclic bloodstream forms Trypanosoma brucei brucei          (Sigma), 1 mM EGTA (Sigma), 1% Nonidet P-40 (Sigma), 1% <br /> Lister 427 used. Procyclic forms grown MEM-Pros             sodium deoxycholate (Sigma), 2.5 mM sodium <span id='am-5' about='obo:IMR_0200280' typeof='owl:Thing obo:IMR_0000947 obo:IMR_0000001 obo:IMR_0001998'><span id='am-6' property="oboInOwl:id" content="IMR:0200280" datatype="xsd:string"></span><span id='am-7' property="oboInOwl:hasDbXref" content="KEGG:C00013" datatype="xsd:string"></span><span id='am-8' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-9' property="rdfs:label" content="Pyrophosphate" datatype="xsd:string"></span>pyrophosphate</span> <br /> medium supplemented 7.5 mg/ml hemin, 10% fetal calf                 (Sigma), 1 mM b-glycerophosphate (Sigma), 1 mM Na3VO4 <br /> serum (FCS) 100 IU/mL penicillin/streptomycin 27uC,            (Sigma)], freshly-added complete protease inhibitor cocktail cell densities 56105 cells/ml 1&#226;&#8364;&#8220;26107 cells/ml.          (Roche Applied Science). total protein quantified <br /> Bloodstream forms grown complete HMI-9 medium                    using Biorad Commercial Kit (Reagents  B S) (supplemented 10% FCS 100 IU/mL penicillin/                  samples kept 280uC. analysis parasites streptomycin) [39] vented tissue culture flasks; cultures       mice, trypanosomes purified mouse blood using  diluted cultures reached cell density 26106/ml          52 (Whatman) column [40]. incubated humidified atmosphere 5% <span id='am-23' about='obo:IMR_0200324' typeof='owl:Thing obo:IMR_0000947 obo:IMR_0000001 obo:IMR_0001998'><span id='am-24' property="oboInOwl:hasDbXref" content="KEGG:C00011" datatype="xsd:string"></span><span id='am-25' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-26' property="oboInOwl:id" content="IMR:0200324" datatype="xsd:string"></span><span id='am-27' property="rdfs:label" content="CO2" datatype="xsd:string"></span>CO2</span>, 37uC.                Western blotting, 2 mg recombinant TbAS TcAS- <br /> Bloodstream RNAi cell cultures supplemented 7.5 mg/            proteins, 10 mg total soluble cell extract, 16107 parasites, <br /> ml hygromycin 0.2 mg/ml phleomycin.                                  resolved SDS/PAGE transferred nitrocellulose <br />  <br />  <br /> PLOS Neglected Tropical Diseases | www.plosntds.org                  2                       December 2013 | Volume 7 | Issue 12 | e2578 <br />                                                                                                                Trypanosoma Asparagine Synthetase  <br />  <br />  <br />  <br /> Figure 1. Multiple-sequence alignment protein. Alignment type asparagine synthetase T. brucei (NCBI-GeneID:3658321/ <br /> Tb927.7.1110), T. cruzi (NCBI-GeneID:3534325/Tc00.1047053503625.10) E. coli (NCBI-GeneID:948258/pdb:12AS). residues colored <br /> according ALSCRIPT Calcons (Aline version 011208) using predefined colour scheme (red: identical residues; orange blue: scale conservation amino acid properties alignment column; white: dissimilar residues). Secondary structure elements EcAS crystal structure (grey) TcAS (purple) TbAS (blue) homology models depicted alignment. protein sequences, asparagine (squares) AMP <br /> binding residues (circles) identified. dashed box indicates structurally divergent region. <br /> doi:10.1371/journal.pntd.0002578.g001 <br />  <br /> Hy-bond ECL membrane (Amersham Biosciences). mem-                            Using query based <span id='am-28' about='obo:IMR_0200467' typeof='owl:Thing obo:IMR_0000947 obo:IMR_0001695 obo:IMR_0000001'><span id='am-29' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-30' property="rdfs:label" content="L-Cysteine" datatype="xsd:string"></span><span id='am-31' property="oboInOwl:hasDbXref" content="KEGG:C00097" datatype="xsd:string"></span><span id='am-32' property="oboInOwl:id" content="IMR:0200467" datatype="xsd:string"></span>L-cysteine</span>-S-sulfinic acid inhibitor [42], <br /> brane blocked 5% (w/v) non-fat dried skimmed milk                   ZINC database screened using program ROCS <br /> PBS/0.1% Tween-20 (blocking solution), followed incubation                 (version 2.3.1) compounds good shape similarity anti tag rabbit antibody (MicroMol-413) (1:5000)             (measured 3D Tanimoto) similar functional group overlap <br /> combination anti-TbAS rabbit antibody (1:1000)                query molecule. L-cysteine-S-sulfate (Sigma; PubChem <br /> anti-aldolase rabbit antibody (1:5000) blocking solution 4uC            Substance <span id='am-88' about='oboInOwl:id' typeof='owl:Thing'>ID</span> 24892471) used following conditions: <br /> O/N, respectively. Blots washed PBS/0.1% Tween-20                   2.5 mM aspartate, 1.25 mM ATP, 12.5 mM ammonia, (3615 min). Horseradish peroxidase-conjugated goat anti-rabbit                8.4 mM Mg2+. characterization mechanism IgG (Amersham) (1:5000 1 h, room temperature) blocking              inhibition consisted determination Km Vmax buffer used secondary antibody. membranes                 substrate, presence inhibitor concentrations (0.025, <br /> developed using SuperSignal WestPico Chemiluminescent Sub-                    0.050, 0.1 0.2 mM). following substrate concentration <br /> strate (Pierce). ImageJ software (version 1.43u) used                 ranges 1.25&#226;&#8364;&#8220;10 1.25&#226;&#8364;&#8220;50 mM used aspartate protein bands semi-quantification.                                            ammonia, respectively, determine Km ATP, range <br />                                                                               0.625 10 mM (TbAS  0.3125 5 mM (TcAS- <br /> Enzyme assays                                                                  assayed. Ki determined &#226;&#8364;&#732;&#226;&#8364;&#732;Km app Method&#226;&#8364;&#8482;&#226;&#8364;&#8482;[43]. <br />    activity assessed quantification asparagine <br /> formation [41]. reactions performed total                    protein alignments TbAS TcAS homology <br /> 150 ml enzyme assay mixture 85 mM Tris-HCl (Sigma)                      models <br /> containing aspartate (Sigma), ammonia (Sigma), ATP (Sigma)                   EcAS  TbAS TcAS protein alignments 8.4 mM Mg2+ (Sigma). Following incubation set times 37uC,              performed using ClustalW [44]. Aline, Version 011208 [45], enzymatic reactions terminated boiling 4 min,                used editing protein sequence alignments preparing Fig. 1. <br /> centrifuged maximum speed 30 s. 100 ml reaction <br />                                                                               TbAS TcAS homology models obtained mixture supernatant added 900 ml ninhydrin 0.05%                                                                               SWISS-MODEL, using EcAS crystal structure (Protein Data <br /> ethanol. resulting mixtures boiled 100uC 5 min, <br />                                                                               Bank (PDB) accession code 12AS [24]) template (percentage centrifuged 30 s maintained ice. 300 ml clear <br />                                                                               sequence identity 56% 57%, respectively) [46&#226;&#8364;&#8220;48]. supernatant fluids transferred 96 plates,                                                                               3D structures rendered PyMOL  PyMOL Molecular <br /> absorbance 340 nm determined [41]. Based reaction <br />                                                                               Graphics  Version 1.3, Schro&#194;&#168;dinger, LLC). <br /> linearity studies, 7.5 mg enzyme 15 min incubation 37uC selected final conditions. determine Kms, concentrations substrates varied following ranges:             Generation TbAS RNAi cell lines <br /> 1.25&#226;&#8364;&#8220;20 mM (aspartate), 0.78&#226;&#8364;&#8220;50 mM (ammonia) 0.62&#226;&#8364;&#8220;                           &#226;&#8364;&#732;&#226;&#8364;&#732;stuffer strategy&#226;&#8364;&#8482;&#226;&#8364;&#8482; used generate RNAi-mediated  <br /> 10 mM (ATP), remaining substrates concentrations                    depletion.  TbASA fragment (amplified sense excess ([aspartate] .20 mM, [ATP] .10 mM,                         oligo BglII &#226;&#8364;&#8220; SphI linker 59 - GAGAAGATCTGCA- <br /> [ammonia] .50 mM). Km glutamine determined using                    TGCGCGACGACGGTTATTCGTCATAC - 39, anti- <br /> concentration range 1.5625&#226;&#8364;&#8220;25 mM, ATP aspartate                  sense oligo EcoRI &#226;&#8364;&#8220; SalI 59 &#226;&#8364;&#8220; CGGAATTCGTCGA- maintained excess. Measurements performed                     CACTCCGTTTTTCGGATTGCGGC &#226;&#8364;&#8220; 39) cloned twice triplicate, initial rate analyzed obtain values Vmax        opposite direction sides &#226;&#8364;&#732;stuffer&#226;&#8364;&#8482; fragment Km curve fitting using GraphPad Prism (5.0 version).                   pHD1144 vector  digested SphI SalI) (Fig. S1A).  <br />  <br /> PLOS Neglected Tropical Diseases | www.plosntds.org                       3                        December 2013 | Volume 7 | Issue 12 | e2578 <br />                                                                                                           Trypanosoma Asparagine Synthetase  <br />  <br />  <br />  <br /> Figure 2. Homology models trypanosomes.   Ribbon representation EcAS colored according sequence similarity TbAS TcAS shown Fig. 1. (B) Superposition EcAS structure (grey) (PDB accession code 12AS), TbAS (blue) TcAS (purple) homology models (obtained SWISS-MODEL server, using PDB 12AS template). small structurally divergent region marked dashed rectangle. Ligand color schemes: asparagine shown yellow (oxygen, red; nitrogen blue) AMP shown brown (oxygen, red; <br /> nitrogen blue; phosphorous orange). <br /> doi:10.1371/journal.pntd.0002578.g002 <br />  <br />  <br /> resulting [(target)-stuffer-(reverse-complement target)] construct         4 groups BALB/c mice (6&#226;&#8364;&#8220;8 weeks old, n = 4) (Harlan <br /> obtained HindIII BglII digestion, generates            Laboratories, United Kingdom) infected intraperitoneal <br /> stem-loop RNA, cloned pHD1145  digested                 injection 104 T. brucei bloodstream forms. 2 groups injected <br /> HindIII BglII) (Fig. S1B). final construct linearized          wt strain  tetracycline) 2 groups NotI 10 mg DNA transfected 26107/ml                   injected RNAi cell line  tetracycline). <br /> bloodstream form cell line carrying pHD1313 plasmid (contains              48 h prior infection 2 RNAi induced groups given copies tet repressor phleomycin resistance                doxycycline (treated 1 mg/ml doxycycline hyclate 5% <br /> cassette) electroporation using Amaxa Basic Parasite Nucleo-            sucrose containing water). 2 non-induced groups given <br /> fector Kit (Lonza). Transcription occurs induction                 standard water. evaluate virulence RNAi induced <br /> tetracycline (100 ng/ml), producing mRNA homologs                 parasites mice reduced plasmatic levels asparagine, target gene. Stable individual clones selected 5 7         animals treated 50 IU E. coli L- asparaginase <br /> days transfection 7.5 mg/ml hygromycin.                      (ProSpec-Tany TechnoGene) 48 h injection                                                                            48 h. According literature, L-asparagine vitro analysis TbAS RNAi                                           detected blood 48 h following intravenous injection E. <br />    analyse growth, T. brucei RNAi cell line cells expressing        coli L-asparaginase, dose 50 IU/mouse [50]. Mice tet repressor (wt), seeded 26105 cells/ml              monitored day general appearance behaviour. <br /> complete HMI9 medium, presence absence                       Parasitemia monitored daily fifth day post-infection, <br /> tetracycline. Cell growth monitored microscopically               using tail-vein blood, haematocytometer microscope. <br /> haemocytometer (Marienfeld) culture diluted                Animals parasitemia greater 108 parasites/ml 26105 cells/ml daily. protocol repeated complete           euthanized, previous studies established levels <br /> HMI9 medium basal IMDM asparagine, complete                   consistently lethal 24 h. <br /> HMI9 medium basal IMDM asparagine supple- <br /> mented 6.76104 nM asparagine (levels human                Immunofluorescence <br /> plasma [49]), complete HMI9 medium basal IMDM                       T. brucei bloodstream forms log-phase cultures, asparagine supplemented 1.676105 nM aspara-                RNAi, fixed m-Chamber 12 (Ibidi) gine (levels normal medium).                                      15 min, room temperature, PBS containing 3% p-formalde- <br />                                                                            hyde, washed twice PBS, permeabilized PBS vivo analysis TbAS RNAi                                            containing 0.1% Triton X-100. Fixed cells incubated   Wild-type transgenic bloodstream T. brucei parasites            60 min PBS containing 10% FCS room temperature (RT), cultured absence selecting drugs (hygromycin                 humidified atmosphere, washed twice PBS/2% FCS. <br /> phleomycin) 24 h, tetracycline added.         Cells incubated primary rat rabbit polyclonal <br /> 48 h, parasites inoculated mice. experiment,              antibody TbAS (1:100 1:5000 respectively,  <br />  <br /> PLOS Neglected Tropical Diseases | www.plosntds.org                    4                       December 2013 | Volume 7 | Issue 12 | e2578 <br />                                                                                                                   Trypanosoma Asparagine Synthetase  <br />  <br />  <br />  <br /> Figure 3. Analysis purified recombinant TcAS TbAS expression T. brucei life cycle stages. Purified TcAS   TbAS (B) recombinant proteins analyzed using 12% SDS-PAGE visualized using Coomassie blue staining. MW, molecular weight <br /> marker. Rabbit anti-histidine monoclonal antibody (1:1000) used immunoblotting assays TcAS   TbAS (B) purified <br /> recombinant proteins. (C) expression T. brucei life-cycle stages: 10 mg protein BS (bloodstream forms) PC (procyclic forms) <br /> lysates analysed Western blot. Aldolase used loading control. Rabbit anti-TbAS anti-aldolase polyclonal antibodies used protein detection. results representative independent experiments. <br /> doi:10.1371/journal.pntd.0002578.g003 <br />  <br /> diluted blocking solution) overnight 4uC, followed                    case TbAS immunolocalization, T. brucei wt bloodstream <br /> washes PBS/2% FCS. Subsequently, cells incubated                      forms cells stained using rat anti-TbAS antibody (1:100 Alexa Fluor 647 conjugated goat anti-rat Alexa Fluor 488                diluted blocking solution), rabbit anti-aldolase antibody (1:5000 <br /> conjugated goat anti-rabbit secondary antibodies (Molecular                     diluted blocking solution), anti-BiP antibody (kindly provided probes Life technologies) (1:500 diluted blocking solution)             Dr. Jay Bangs, 1:500 diluted blocking solution), anti-enolase 1 h RT humidified atmosphere, washed twice                    antibody (kindly provided Dr. Paul Michels, 1:5000 diluted PBS.  slides stained mounted                        blocking solution) anti-GRASP antibody (kindly provided Vectashield-DAPI (Vector Laboratories, ). Images                       Dr. Graham Warren, 1:200 diluted blocking solution). Alexa <br /> captured using fluorescence microscope AxioImager Z1                        Fluor 647 conjugated goat anti-rat (1:500) Alexa Fluor 488 <br /> software Axiovision 4.7 (Carl Zeiss, Germany). Pseudo-coloring                  conjugated goat anti-rabbit (1:500) used secondary images carried using ImageJ software (version 1.43u).                antibodies. Staining MitoTracker Orange (Invitrogen) <br />                                                                                 followed Alexa Fluor 488 conjugated goat anti-rabbit (1:500), <br />  <br />  <br />  Table 1. TbAS TcAS kinetic parameters aspartate, ATP ammonia. <br />  <br />  <br />  Species              Substrate                 Km (mM)                   Vmax 61023(mM.s21)        kcat (s21)               kcat/Km (M21.s21) <br />  <br />  T. brucei            Aspartate                 5.3960.31                 6.7260.14                 5.3160.11                9.856102 <br />                       ATP                       1.8060.32                 7.8860.48                 6.2260.38                3.466103 <br />                       Ammonia                   5.5560.41                 7.2160.16                 5.6960.13                1.036103 <br />  T. cruzi             Aspartate                 6.4562.05                 3.0960.40                 2.4160.32                3.746102 <br />                       ATP                       0.7260.01                 4.4260.02                 3.4560.02                4.796103 <br />                       Ammonia                   7.7561.55                 3.1460.21                 2.4560.17                3.166102 <br />  <br />  values means 6 standard deviation obtained 3 independent experiments. <br />  doi:10.1371/journal.pntd.0002578.t001 <br />  <br />  <br />  <br /> PLOS Neglected Tropical Diseases | www.plosntds.org                         5                       December 2013 | Volume 7 | Issue 12 | e2578 <br />                                                                                                                 Trypanosoma Asparagine Synthetase  <br />  <br />  <br />  Table 2. TbAS TcAS kinetic parameters                               sequence alignment, performed using ClustalW [44],  glutamine.                                                                      T. brucei (Tb927.7.1110, NCBI-GeneID:3658321), T. cruzi <br />                                                                                  (Tc00.1047053503625.10, NCBI-GeneID:3534325) E. coli <br />                                                                                  (NCBI-GeneID:948258) shown Figure 1. amino acid <br />                             Vmax 61023                                           residues known involved active-site formation E. coli <br />  Species     Km(mM)         (mM.s21)   kcat(s21)       kcat/Km (M21.s21)         [24] highly conserved sequences (Fig. 1). <br />                                                                                  Protein alignments demonstrated 58% similarity EcAS versus <br />  T. brucei   8.2061.70      7.0660.61    5.5860.48     6.806102 <br />                                                                                  TbAS  60% EcAS versus TcAS  63% TbAS  T. cruzi    15.3363.66     4.3360.53    3.3860.41     2.206102                  versus TcAS  <br />  values means 6 standard deviation obtained 3 independent          Like EcAS  TbAS TcAS predicted dimeric,  experiments.                                                                    seen superimposed homology models EcAS crystal <br />  doi:10.1371/journal.pntd.0002578.t002                                           structure [24] (Fig. 2A). structurally divergent region <br />                                                                                  (area marked dashed rectangle) (Fig. 1, 2B), present secondary antibody. labelling parasites                         TbAS  residues Q232 S250) TcAS  residues <br /> MitoTracker adding 250 nM cell culture                        D232 S247), absent EcAS  region distant medium  FCS) 30 minutes, prior washing, fixing                    enzyme active site dimer interface functional staining using protocol described  Images                     structural significance unknown. amino acids <br /> captured using confocal microscope Leica TCS SP5II                       involved asparagine binding strictly conserved, LAS 2.6 software (Leica Microsystems, Germany).  image                     AMP binding pocket, majority residues analysis using ImageJ version 1.43U software.                           conserved, residues (Fig. 1). EcAS  E103 <br />                                                                                  (D106 E106 TbAS TcAS  respectively) L109 <br /> Digitonin permeabilization                                                       (I112 T112 TbAS TcAS  respectively) (Fig. 1)    sample condition, 1.06107 bloodstream cells                     directly involved polar interactions <span id='am-49' about='obo:IMR_0001349' typeof='owl:Thing obo:IMR_0001657 obo:IMR_0000947 obo:IMR_0000001 obo:IMR_0001698'><span id='am-50' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-51' property="rdfs:label" content="nucleotide" datatype="xsd:string"></span><span id='am-52' property="oboInOwl:hasDbXref" content="CHEBI:25608" datatype="xsd:string"></span><span id='am-53' property="oboInOwl:hasExactSynonym" content="nucleoside phosphate" datatype="xsd:string"></span><span id='am-54' property="oboInOwl:id" content="IMR:0001349" datatype="xsd:string"></span><span id='am-55' property="obo:IAO_0000115" content="A nucleotide consists of a nitrogen-containing base, a five-carbon sugar, and one or more phosphate groups. Nucleotides can carry chemical energy (e.g. ATP), form coenzymes (e.g. CoA), be used as specific signaling molecules (e.g. cAMP) in the cell. Nucleotides are the subunits of the nucleic acids. " datatype="xsd:string"></span><span id='am-56' property="rdfs:label" content="nucleoside phosphate" datatype="xsd:string"></span>nucleotide</span> base, <br /> washed cold trypanosome homogenization buffer                          form outer wall binding site [24]. main <br /> (THB), containing 25 mM Tris (Sigma), 1 mM EDTA (Sigma)                          chain L249 EcAS (V271 L268 TbAS TcAS- 10% sucrose (Sigma), pH = 7.8. Just cell lysis, leupeptin              respectively) directly involved hydrogen bonds ribose <br /> (Sigma) (final concentration 2 mg/ml) different digitonin                 AMP, different chains leucine valine <br /> (Calbiochem) quantities (final concentrations 5, 12.5, 25, 50,                affect shape AMP binding site. <br /> 100, 150 200 ug/ml) added 500 ml cold THB, cell pellet resuspension. Untreated cells (0 mg/ml digitonin)             Trypanosome catalyze asparagine synthesis using completely permeabilized (total release, result                     ammonia glutamine nitrogen donors <br /> incubation 0.5% Triton X-100) used controls.                        TbAS TcAS coding sequences cloned sample incubated 60 min ice, centrifuged                      bacterial expression vector pET28a. Histidine-tagged fusion <br /> 2000 rpm, 4uC, 10 min. Supernatants transferred new                  proteins purified non-denaturing conditions (Fig. 3A, <br /> chilled tubes 500 ml cold THB added pellet                B). expected, recombinant proteins recognized mixed. fractions analysed Western blot                  anti Tag monoclonal antibody (Fig. 3A, B). Rabbit polyclonal <br /> described                                                                  antibodies produced recombinant TbAS recognized                                                                                  protein total extracts different parasite developmental <br /> Cell cycle analysis                                                              stages, bloodstream forms (mammalian host parasite stage)    T. brucei bloodstream forms analyzed flow cytometry               procyclic forms (insect vector parasite stage) (Fig. 3C). <br /> DNA content following RNAi induction. Cells collected                       capacities TbAS TcAS produce asparagine <br /> centrifugation washed twice PBS containing 2% FCS.                      aspartate presence ATP, ammonia Mg2+ 26106 cells resuspended 1 mL PBS/2% FCS                      determined using specific quantitative colorimetric assay L- <br /> 3 mL cold absolute ethanol added vortexing. Cells                   asparagine [41]. pH optimum 7.6, detectable fixed 1 hour 4uC washed twice PBS. 1 mL               activity 6.0 9.0 (data shown). Mg2+ essential  <br /> staining solution [3.8 mM sodium citrate dehydrate (Sigma),                      factor TbAS TcAS (data shown), previously <br /> 50 mg/mL propidium iodide (Sigma), 0.5 mg/mL RNAse (Sigma)                     described EcAS [22]. included 8.4 mM Mg2+ final PBS] added cell pellets vortex. Samples                   reaction mixture. Lower concentrations (2, 4 6 mM) gave <br /> analysed FACS (Becton Dickinson) incubation 4uC                lower activity increased concentrations  16 mM) <br /> 30 min. Data analyzed FlowJo software (Ashland, .                      resulted substantial activity improvement (data shown). <br />                                                                                  TbAS TcAS showed similar Kms aspartate Statistical analysis                                                             ammonia (p.0.01), TcAS showed higher Km ATP    way ANOVA tailed Student&#226;&#8364;&#8482;s test used                     TbAS (p = 0.0042) (Table 1). ATP substrate required statistical analysis. Statistical analysis performed using                   generation b-aspartyl adenylate intermediate, GraphPad Prism Software (version 5.0), p values#0.01                    reacts ammonia, releasing asparagine. absence, considered statistically significant. Asterisks indicate statis-           reaction did occur (data shown). surprise, tically significant differences (*** p#0.001, ** p#0.01).                        TbAS TcAS use glutamine nitrogen donor <br />                                                                                  (Table 2). TbAS showed higher Km nitrogen donor Results                                                                          TcAS  statistically significant (p.0.01).                                                                                  enzymes present higher Km values ammonia Conservation trypanosomes                                             glutamine, differences statistically significant <br />    open reading frame code putative present               (p.0.01) (Table 1 2). TbAS higher Vmax TcAS- genomes T. cruzi CL Brener Non-Esmeraldo-like T.                    ammonia (p,0.0001) glutamine (p = 0.0043) <br /> brucei TREU927 (http://tritrypdb.org) [29&#226;&#8364;&#8220;31]. protein multiple                dependent-activities (Table 1 2). TbAS similar catalytic <br />  <br />  <br /> PLOS Neglected Tropical Diseases | www.plosntds.org                          6                        December 2013 | Volume 7 | Issue 12 | e2578 <br />                                                                    Trypanosoma Asparagine Synthetase  <br />  <br />  <br />  <br /> PLOS Neglected Tropical Diseases | www.plosntds.org   7   December 2013 | Volume 7 | Issue 12 | e2578 <br />                                                                                                                 Trypanosoma Asparagine Synthetase  <br />  <br />  <br /> Figure 4. T. brucei T. cruzi vitro inhibition.   Inhibition (%) T. brucei T.cruzi activity L-cysteine-S-sulfate (L-CS). (B) <br /> Plot Kmapp/Vmax versus L-CS concentration established; Ki corresponds symmetric value X-axis intersection. (C-H) Plots showing effect different L-CS concentrations inverse initial velocity versus inverse concentrations ATP, aspartate ammonia TbAS (C, E G, respectively) TcAS (D, F H, respectively) enzymes. Error bars indicate standard deviation means replicates data shown representative independent experiments. <br /> doi:10.1371/journal.pntd.0002578.g004 <br />  <br /> rates glutamine ammonia-dependent activities                      aspartate ammonia observed (p.0.01) (Fig. 4E, F, G, H), <br /> (p.0.01), TcAS presented slightly higher,                  suggesting inhibition exclusively ATP binding <br /> statistically significant, rate glutamine-dependent activity               interference (p#0.01) . Ki values 137 128.9 mM (p.0.01) (Table 1 2). high conservation active                  determined TbAS TcAS  respectively (Fig. 4B). <br /> sites small amino acid differences identified homology models allow accurate structural interpreta-                localizes cytosol T. brucei bloodstream <br /> tion small differences observed.                forms slight differences proportion protein              subcellular localization TbAS determined correctly folded.                                                              immunofluorescence digitonin fractionation bloodstream <br />    L-cysteine-S-sulfate, considered putative inhibitor             forms. expected, induction RNAi resulted decrease virtual screening, inhibited enzymes, IC50s 126             fluorescence intensity (Fig. S2A, B, C). TbAS 100 mM TbAS TcAS  respectively (Fig. 4A).                 cytosol, revealed colocalization cytosolic enzyme <br /> enzymes, kinetic characteristics suggested competition                enolase [51] (Fig. 5A) colocalization aldolase, BiP, <br /> ATP binding (Fig. 4C, D). changes Kms Vmaxs                  GRASP mitotracker (Fig. S3), markers glycosomes [52], <br />  <br />  <br />  <br />  <br /> Figure 5. subcellular localization T. brucei bloodstream forms.   Immunofluorescence analysis confocal microscopy TbAS (red) enolase (green) bloodstream forms. DAPI locate nuclear kinetoplast mitochondrial DNA (blue). Bar, 5 mm. Images maximal  <br /> projections 50 contiguous stacks separated 0.1 mm. (B) digitonin permeabilization, selected supernatant (S) pellet (P) fractions obtained different digitonin concentrations subjected Western-blot analysis probed rabbit antisera raised TbAS  enolase <br /> (cytoplasmic marker) aldolase (glycosome marker). Data shown representative independent experiments. Untreated cells (0 mg/ml digitonin) completely permeabilized Triton X-100 0.5% used controls. <br /> doi:10.1371/journal.pntd.0002578.g005 <br />  <br />  <br /> PLOS Neglected Tropical Diseases | www.plosntds.org                        8                         December 2013 | Volume 7 | Issue 12 | e2578 <br />                                                                                                                Trypanosoma Asparagine Synthetase  <br />  <br />  <br />  <br /> Figure 6. vitro effect RNAi-mediated regulation T. brucei bloodstream forms. Growth curve wt versus representative RNAi cell line performed unmodified medium [complete HMI-9 (HMI-9c) basal IMDM]  , modified medium [HMI-9c basal medium asparagine - HMI-9c (basal IMDM w/o Asn)] (C), modified medium supplemented 6.76104 nM asparagine [HMI-9c <br /> (basal IMDM w/o Asn + 6.76104 nM Asn)] (E), modified medium supplemented 1.676105 nM asparagine [HMI-9c (basal IMDM w/o Asn + <br /> 1.676105 nM Asn)] (G). Circles squares represent wild-type growth absence presence tetracycline, respectively, triangles triangles represent clones growth absence presence tetracycline, respectively. Cumulative cell numbers plotted product <br />  <br />  <br />  <br /> PLOS Neglected Tropical Diseases | www.plosntds.org                       9                        December 2013 | Volume 7 | Issue 12 | e2578 <br />                                                                                                                Trypanosoma Asparagine Synthetase  <br />  <br />  cell number total dilution. Error bars indicate standard deviation. effect RNAi protein levels analyzed Western blots extracts noninduced tet(2), RNAi-induced tet(+) cells, isolated unmodified medium (B), modified medium (complete HMI-9 medium basal IMDM asparagine) (D), modified medium supplemented 6.76104 nM asparagine (F), modified medium supplemented 1.676105 nM asparagine (H). Cells collected day 1, 2, 6 10 RNAi induction. Results representative independent <br /> experiments. <br /> doi:10.1371/journal.pntd.0002578.g006 <br />  <br />  <br />  <br /> endoplasmic reticulum [53], Golgi mitochondria compart-                   HMI-9 medium asparagine fetal calf serum, <br /> ments [54], respectively. Controls performed rat rabbit               growth impaired, increase proportion cells pre-immune sera secondary antibody  showed                       G0/G1 (Fig. 6C 7B, C). Presumably asparagine detectable signal (data shown). Digitonin fractionation              serum allowed slower growth. Levels asparagine usually <br /> resulted similar profiles enolase (cytosolic                  human serum (6.76104 nM) [49], somewhat <br /> marker) similarity aldolase (glycosomes marker)                     lower normal medium (1.676105 nM; IMDM - Iscove&#226;&#8364;&#8482;s <br /> (Fig. 5B).                                                                    modified Dulbecco&#226;&#8364;&#8482;s basal medium Gibco Invitrogen),                                                                               sufficient overcome defect (Fig. 6E, G). complete HMI-9 knockdown makes T. brucei bloodstream forms                              medium, asparagine fetal calf serum, dependent extracellular asparagine                                         growth defects induced RNAi clones abrogated day 5 <br />    study biological role T. brucei bloodstream              post-induction (Fig. 6C, 7D), percentage cells  <br /> forms, cells stably transfected RNA interference                 G1 S phases cell cycle return ones non- <br /> plasmid construct. RNAi asparagine synthetase                   induced cells (Fig. 7A), suggesting appearance RNAi <br /> induced normal medium (complete HMI-9) adding                           revertants, visible Western blot (Fig. 6D). Similar <br /> tetracycline. difference observed cell proliferation                reversion evade lethal RNAi trypanosomes seen induced non-induced cells (Fig. 6A),                times [55]. presence asparagine, low protein reduced &lt;13% normal level 48 hours               levels maintained (Fig. 6B, F H). <br /> (Fig. 6B).   depleted cells grown  <br />  <br />  <br />  <br /> Figure 7. vitro effect RNAi-mediated downregulation T. brucei cell cycle. DNA content &lt;26106 wt RNAi cell line parasites <br /> grown completed HMI-9 medium basal IMDM asparagine, collected tetracycline induction, day 0  , day 1 (B), 3 <br /> (C), 5 (D) post-induction, cell cycle analysis. Samples analysed flow cytometry percentage cells phase cell <br /> cycle determined using FlowJo software. bar represents average replicates. Error bars indicate standard deviation measurements. statistics calculated way ANOVA (*** p#0.001 ** p#0.01). <br /> doi:10.1371/journal.pntd.0002578.g007 <br />  <br />  <br /> PLOS Neglected Tropical Diseases | www.plosntds.org                      10                        December 2013 | Volume 7 | Issue 12 | e2578 <br />                                                                                                                  Trypanosoma Asparagine Synthetase  <br />  <br />  <br />  <br /> Figure 8. vivo effect RNAi TbAS    Groups 4 mice infected intraperitoneally, 16104 control wt parental cell line <br /> (open squares open diamonds) representative RNAi clone (open triangles open circles). mice untreated (open <br /> squares open triangles) treated 1 mg/ml doxycycline (Dox) (open diamonds open circles) water supply. Parasitemia quantified times indicated. Error bars indicate standard deviation means mice wt cell lines, mice case RNAi cell lines. detection limit assay 56104 trypanosomes ml blood. Mice euthanized parasitemia reached 16108 <br /> cells/ml. (B) Kaplan&#226;&#8364;&#8220;Meier survival analysis mice infected wt parental cell line RNAi cell line absence presence doxycycline. <br /> Data representative independent experiments. Western blot analysis levels trypanosomes injected mice, 48 h vitro tetracycline induction (C), trypanosomes isolated mice, euthanized (D). <br /> doi:10.1371/journal.pntd.0002578.g008 <br />  <br />  <br />    Normal T. brucei parasites showed statistically significant           appeared course infection asparaginase-treated, <br /> slower growth conditions asparagine limitation (p#0.01;                untreated, mice (Fig. 9F). Parasites extracts wt <br /> data shown) (compare Fig. 6C,  E, G).                infected mice used controls (Fig. 9C). <br /> possible parasite  requires <br /> external asparagine optimal vitro growth.                                Discussion <br />  dispensable T. brucei infectivity mice                              study demonstrated trypanosomes use    test important parasite infection                ammonia glutamine nitrogen donors ATP dependent <br /> disease model, groups mice (n = 4) inoculated              conversion aspartate asparagine. hybrid activity parental cell line, groups RNAi cells. mice              previously demonstrated type B enzymes, prefer <br /> groups fed water containing doxycycline induce                     glutamine ammonia [15&#226;&#8364;&#8220;19]. small differences Km regulation TbAS  remaining mice kept                   TbAS TcAS ammonia glutamine (1.5 2 fold, non-induced controls. days inoculation, mice               respectively) lower difference B different groups developed high levels parasitemia                  enzymes, exception human enzyme, (Fig. 8A), euthanized seven days               similar affinities [16&#226;&#8364;&#8220;20]. Purified E. coli used post-infection (Fig. 8B). results confirm asparagine            ammonia nitrogen source, results Klebsiella aerogenes <br /> mouse blood sufficient compensate &lt;87% downreg-                   suggested preferentially uses ammonia substrate <br /> ulation (Fig. 8C, D).                                                   [5,21,22]. conclusions enzymes Gram- <br />    assess contribution blood L-asparagine vivo, mice               negative organisms relied biochemical genetic treated L-asparaginase [50]. L-asparaginase treatment                 analysis, given technical limitations time, fact <br /> did affect growth normal parasites mice (Fig. 9A)                 background enzyme activity seen absence consequently did extend animal survival (Fig. 9B). L-               ammonia glutamine, examination bacteria asparaginase treatment mice infected TbAS RNAi-                       worthwhile. overall Km values trypanosomes <br /> induced parasites caused decrease parasitemia (Fig. 9D),               aspartate, 6 20 fold higher ones leading increase mice survival (Fig. 9E).             literature prokaryotic asparagine synthetase type infection resulted death. happened vitro, RNAi revertants              [5,21,22]. Trypanosoma structures solved <br />  <br />  <br /> PLOS Neglected Tropical Diseases | www.plosntds.org                        11                        December 2013 | Volume 7 | Issue 12 | e2578 <br />                                                                                                                Trypanosoma Asparagine Synthetase  <br />  <br />  <br />  <br /> Figure 9. vivo RNAi TbAS mice undergoing E. coli L-asparaginase treatment. Time course parasitemia groups 4 mice infected intraperitoneally, 16104 RNAi induced [using 1 mg/ml doxycycline, Dox (+)] wt parental cell line   representative RNAi cell line (D) untreated (open squares) treated daily 2 days (open diamonds) 50 IU E. coli L-asparaginase/mouse. <br /> Parasitemia quantified peripheral tail blood times indicated. Error bars indicate standard deviation, data representative independent experiments using different RNAi clones. detection limit assay 56104 trypanosomes/ml blood. Mice culled parasitemia reached 16108 cells/ml. Kaplan&#226;&#8364;&#8220;Meier survival plot mice infected RNAi induced wt cell line (B) RNAi cell line (E) untreated (open squares) treated (open diamonds) E. coli L-asparaginase. (F) Western blot analysis levels trypanosomes isolated mice, euthanized. (C) Wt cell extracts, collected mice culled, use negative control. <br /> doi:10.1371/journal.pntd.0002578.g009 <br />  <br />  protein homology models completely enlightening,               extracellular medium biosynthesis  speculate differences result              Bloodstream form proliferation, vitro vivo, fact parasite enzymes expressed purified                  significantly affected asparagine sources compro- <br /> recombinant proteins bacteria purified directly                mised. consistent idea, published RNAi <br /> trypanosomes extracts. consequence, differences protein                screen, slight (possibly insignificant) growth disadvantage <br /> post-transcriptional processing changes protein confor-              seen bloodstream forms depleted [56]. mation excluded.                                                     way, vitro results corroborated previous studies,    results suggest bloodstream-form parasites rely             mammalian cells low expression similarly <br /> major sources asparagine ensure normal proliferation: uptake             susceptible asparagine depletion [57&#226;&#8364;&#8220;59], asparaginase <br />  <br />  <br /> PLOS Neglected Tropical Diseases | www.plosntds.org                       12                        December 2013 | Volume 7 | Issue 12 | e2578 <br />                                                                                                                                     Trypanosoma Asparagine Synthetase  <br />  <br /> isolated E. coli Erwinia carotovora act potent anti-                              inducible EP1 promoter hygromycin resistance cassette, <br /> leukemic agents [60].                                                                         insertion ribosomal spacer). <br />    trypanosomes genome second open reading                                  (TIF) <br /> frame (Tb927.3.4060) coding putative domain.                                 Figure S2 Validation antibodies TbAS  apparently classical  despite presence good                         Immunofluorescence analysis T. brucei wt representative <br /> Pfam domain (PF0073) C-terminus. BLASTp search                                    RNAi clone grown presence absence tetracycline. <br /> using T. brucei sequence revealed variety proteins                                RNAi induced uninduced cells grown 48 h, unknown function aligned domain,                              fixed probed rat polyclonal anti-TbAS   rabbit N-terminal region, contains N-terminal                                      polyclonal anti-TbAS (B) antibody stained DAPI. <br /> aminohydrolase domains. Best matches originate extremely                                 Bars, 5 mm. Quantification TbAS fluorescence levels diverse eukaryotes including plant, alga, member                                    induced cells  RNAi tet(+), n = 30) uninduced cells  fungi amoeba. BLASTp Saccharomyces                                     RNAi tet(2), n = 30), using rat rabbit polyclonal anti- <br /> cerevisiae predicted proteome yielded YML096W, reci-                                  TbAS antibodies (C). Data representative independent <br /> procal BLASTp trypanosome genome gave                                           experiments using different clones. ImageJ software (version <br /> Tb927.3.4060 best match. function YML096W                                    1.43u) used fluorescence quantification. p value known, trypanosome RNAi screen growth defect                                  calculated Student&#226;&#8364;&#8482;s t test (*** p#0.001 ** p#0.01). <br /> seen Tb927.3.4060 [56].                                                                   (TIF) <br />    capacity trypanosomes grow using asparagine extracellular environment, lack growth defect                             Figure S3 TbAS cellular localization T. brucei levels reduced, combination                                  bloodstream forms. Immunofluorescence analysis confocal <br /> therapy using TbAS inhibitor extracellular                                    microscopy TbAS (red) bloodstream forms. Aldolase <br /> asparagine depletor (e.g. L-asparaginase) asparagine                                    (glycosome marker), GRASP (golgi marker), BiP (endoplasmic <br /> transport blocker inhibit parasite growth.                                  reticulum marker) MitoTracker (labels mitochondria) appropriate African sleeping sickness treatment. combina-                               green. DAPI locate nuclear kinetoplast mitochondrial DNA <br /> tion absolutely required simultaneous activities                                  (blue). Bars, 5 mm. Images maximal projections 50 <br /> different drugs wide open resistance development,                                 contiguous stacks separated 0.1 mm. drug combination including intravenously-introduced                                    (TIF) <br /> enzyme likely expensive logistically <br /> inappropriate treatment African trypanosomiasis.                              Acknowledgments <br /> L-asparaginase treatment cancer results adverse                                 like thank Dr. Jay Bangs University Wisconsin- <br /> events [61&#226;&#8364;&#8220;63]. conclude good                                 Madison Medical School, USA, providing BiP antibody, Dr. Paul <br /> candidate sleeping sickness drug target. role Trypanosoma                         Michels Universite&#194;&#180; Catholique Louvain, Belgium, sending cruzi,  remains established.                                                    enolase antibody Dr. Graham Warren Yale University School                                                                                               Medicine, USA, GRASP antibody. thank Claudia Helbig <br />                                                                                               assistance Heidelberg. <br /> Supporting Information <br /> Figure S1 RNAi vectors used generate RNAi-mediat-                                          Author Contributions <br /> ed TbAS downregulation.   pHD1144 vector stem-                                        Conceived designed experiments: JF JT ACdS. Performed loop cloning (pSP72 vector stuffer fragment); (B) pHD1145                              experiments: JF NS JT. Analyzed data: JF SMR CC JT ACdS. <br /> inducible polymerase vector insertion ready stem-                               Contributed reagents/materials/analysis tools: CC SMR NR. Wrote loops (pHD677 vector T7 promoter                                        paper: JF CC SMR JT ACdS. <br />  <br /> References <br />  1. Richards NG, Schuster SM (1998) Mechanistic issues asparagine synthetase               10. Andrulis  Chen J, Ray PN (1987) Isolation human cDNAs asparagine <br />     catalysis. Adv Enzymol Relat Areas Mol Biol 72: 145&#226;&#8364;&#8220;198.                                      synthetase expression Jensen rat sarcoma cells. Mol Cell Biol 7: 2435&#226;&#8364;&#8220; <br />  2. Blaise M, Frechin M, Olieric V, Charron C, Sauter C, et al. (2011) Crystal                    2443. <br />     structure archaeal asparagine synthetase: interrelation aspartyl-tRNA         11. Andrulis  Shotwell M, Evans-Blackler S, Zalkin H, Siminovitch L, et al. <br />     asparaginyl-tRNA synthetases. J Mol Biol 412: 437&#226;&#8364;&#8220;452.                                    (1989) Fine structure analysis Chinese hamster gene encoding <br />  3. Roy H, Becker HD, Reinbolt J, Kern D (2003) contemporary aminoacyl-                      asparagine synthetase. Gene 80: 75&#226;&#8364;&#8220;85. <br />     tRNA synthetases invent cognate amino acid metabolism. Proc Natl Acad               12. Ramos F, Wiame JM (1980) asparagine synthetases Saccharomyces <br />     Sci U S 100: 9837&#226;&#8364;&#8220;9842.                                                                     cerevisiae. Eur J Biochem 108: 373&#226;&#8364;&#8220;377. <br />  4. Nakamura M, Yamada M, Hirota Y, Sugimoto K, Oka  et al. (1981)                          13. Merchant SS, Prochnik SE, Vallon O, Harris EH, Karpowicz SJ, et al. (2007) <br />     Nucleotide sequence asnA gene coding asparagine synthetase E. coli              Chlamydomonas genome reveals evolution key animal plant <br />     K-12. Nucleic Acids Res 9: 4669&#226;&#8364;&#8220;4676.                                                         functions. Science 318: 245&#226;&#8364;&#8220;250. <br />  5. Reitzer LJ, Magasanik B (1982) Asparagine synthetases Klebsiella aerogenes:            14. Coruzzi GM (2003) Primary N-assimilation Amino Acids Arabidopsis. <br />     properties regulation synthesis. J Bacteriol 151: 1299&#226;&#8364;&#8220;1313.                           Arabidopsis Book 2: e0010. <br />  6. Blattner FR, Plunkett G, 3rd, Bloch CA, Perna NT, Burland V, et al. (1997)                15. Boehlein SK, Richards NG, Schuster SM (1994) Glutamine-dependent nitrogen <br />     complete genome sequence Escherichia coli K-12. Science 277: 1453&#226;&#8364;&#8220;                     transfer Escherichia coli asparagine synthetase B. Searching catalytic <br />     1462.                                                                                         triad. J Biol Chem 269: 7450&#226;&#8364;&#8220;7457. <br />  7. Sugiyama  Kato H, Nishioka T, Oda J (1992) Overexpression purification              16. Duff SM, Qi Q, Reich T, Wu X, Brown T, et al. (2011) kinetic comparison     asparagine synthetase Escherichia coli. Biosci Biotechnol Biochem 56:                 asparagine synthetase isozymes higher plants. Plant Physiol Biochem 49: <br />                                                                                                   251&#226;&#8364;&#8220;256. <br />     376&#226;&#8364;&#8220;379. <br />                                                                                               17. Ramos F, Wiame JM (1979) Synthesis activation asparagine asparagine <br />  8. Gowri VS, Ghosh  Sharma  Madhubala R (2012) Unusual domain <br />                                                                                                   auxotrophs Saccharomyces cerevisiae. Eur J Biochem 94: 409&#226;&#8364;&#8220;417. <br />     architecture aminoacyl tRNA synthetases paralogs Leishmania <br />                                                                                               18. Horowitz B, Meister (1972) Glutamine-dependent asparagine synthetase     major. BMC Genomics 13: 621. <br />                                                                                                   leukemia cells. Chloride dependence, mechanism action, inhibition. J Biol <br />  9. Humbert R, Simoni RD (1980) Genetic biomedical studies demonstrating                                                                                                   Chem 247: 6708&#226;&#8364;&#8220;6719. <br />     second gene coding asparagine synthetase Escherichia coli. J Bacteriol 142: <br />                                                                                               19. Patterson MK Jr OG (1968) Asparagine biosynthesis Novikoff Hepatoma <br />     212&#226;&#8364;&#8220;220. <br />                                                                                                   isolation, purification, property, mechanism studies enzyme  <br />                                                                                                   J Biol Chem 243: 376&#226;&#8364;&#8220;380. <br />  <br />  <br />  <br /> PLOS Neglected Tropical Diseases | www.plosntds.org                                      13                             December 2013 | Volume 7 | Issue 12 | e2578 <br />                                                                                                                                    Trypanosoma Asparagine Synthetase  <br />  <br /> 20. Ciustea M, Gutierrez JA, Abbatiello SE, Eyler JR, Richards NG (2005)                    41. Sheng S, Kraft JJ, Schuster SM (1993) specific quantitative colorimetric assay <br />     Efficient expression, purification, characterization C-terminally tagged,            L-asparagine. Anal Biochem 211: 242&#226;&#8364;&#8220;249. <br />     recombinant human asparagine synthetase. Arch Biochem Biophys 440:                      42. Fresquet V, Thoden JB, Holden HM, Raushel FM (2004) Kinetic mechanism     18&#226;&#8364;&#8220;27.                                                                                      asparagine synthetase Vibrio cholerae. Bioorg Chem 32: 63&#226;&#8364;&#8220;75. <br /> 21. Cedar H, Schwartz JH (1969) asparagine synthetase Escherichia coli. II.          43. Kakkar T, Boxenbaum H, Mayersohn M (1999) Estimation Ki     Studies mechanism. J Biol Chem 244: 4122&#226;&#8364;&#8220;4127.                                           competitive enzyme-inhibition model: comparisons methods 22. Cedar H, Schwartz JH (1969) asparagine synthetase Escherhic coli.                  data analysis. Drug Metab Dispos 27: 756&#226;&#8364;&#8220;762. <br />     Biosynthetic role enzyme, purification, characterization              44. Larkin MA, Blackshields G, Brown NP, Chenna R, McGettigan PA, et al. (2007) <br />     reaction products. J Biol Chem 244: 4112&#226;&#8364;&#8220;4121.                                              Clustal W Clustal X version 2.0. Bioinformatics 23: 2947&#226;&#8364;&#8220;2948. <br /> 23. Larsen TM, Boehlein SK, Schuster SM, Richards NG, Thoden JB, et al. (1999)              45. Bond CS, Schuttelkopf AW (2009) ALINE: WYSIWYG protein-sequence <br />     dimensional structure Escherichia coli asparagine synthetase B: short            alignment editor publication-quality alignments. Acta Crystallogr D Biol <br />     journey substrate product. Biochemistry 38: 16146&#226;&#8364;&#8220;16157.                            Crystallogr 65: 510&#226;&#8364;&#8220;512. <br /> 24. Nakatsu T, Kato H, Oda J (1998) Crystal structure asparagine synthetase              46. Arnold K, Bordoli L, Kopp J, Schwede T (2006) SWISS-MODEL <br />     reveals close evolutionary relationship class II aminoacyl-tRNA synthetase.            workspace: web-based environment protein structure homology modelling. <br />     Nat Struct Biol 5: 15&#226;&#8364;&#8220;19.                                                                   Bioinformatics 22: 195&#226;&#8364;&#8220;201. <br /> 25. Nakatsu T, Kato H, Oda J (1996) Crystallization preliminary crystallo-              47. Kiefer F, Arnold K, Kunzli M, Bordoli L, Schwede T (2009) SWISS- <br />     graphic study asparagine synthetase Escherichia coli. Acta                          MODEL Repository associated resources. Nucleic Acids Res 37: D387&#226;&#8364;&#8220;392. <br />     Crystallogr D Biol Crystallogr 52: 604&#226;&#8364;&#8220;606.                                             48. Peitsch MC, Wells TN, Stampf DR, Sussman JL (1995) Swiss-3DImage <br /> 26. Boehlein SK, Stewart JD, Walworth ES, Thirumoorthy R, Richards NG, et al.                   collection PDB-Browser World-Wide Web. Trends Biochem Sci 20: <br />     (1998) Kinetic mechanism Escherichia coli asparagine synthetase B.                       82&#226;&#8364;&#8220;84. <br />     Biochemistry 37: 13230&#226;&#8364;&#8220;13238.                                                           49. Cooney DA, Capizzi RL, Handschumacher (1970) Evaluation L- <br /> 27. Luehr CA, Schuster SM (1985) Purification characterization beef                      asparagine metabolism animals man. Cancer Res 30: 929&#226;&#8364;&#8220;935. <br />     pancreatic asparagine synthetase. Arch Biochem Biophys 237: 335&#226;&#8364;&#8220;346.                    50. Goldberg AI, Cooney DA, Glynn JP, Homan ER, Gaston MR, et al. (1973) 28. Huang XH, HM; Raushel, F (2001) Channeling substrates                            effects immunization L-asparaginase antitumor enzymatic activity. <br />     intermediates enzyme-catalyzed reactions. Annual Review Biochemistry                  Cancer Res 33: 256&#226;&#8364;&#8220;261. <br />     70: 149&#226;&#8364;&#8220;180.                                                                            51. Hannaert V, Albert MA, Rigden DJ, da Silva Giotto MT, Thiemann O, et al. <br /> 29. Berriman M, Ghedin E, Hertz-Fowler C, Blandin G, Renauld H, et al. (2005)                   (2003) Kinetic characterization, structure modelling studies crystallization     genome African trypanosome Trypanosoma brucei. Science 309:                      Trypanosoma brucei enolase. Eur J Biochem 270: 3205&#226;&#8364;&#8220;3213. <br />     416&#226;&#8364;&#8220;422.                                                                                52. Clayton CE (1987) Import fructose bisphosphate aldolase glycosomes <br /> 30. El-Sayed NM, Myler PJ, Bartholomeu DC, Nilsson D, Aggarwal G, et al. (2005)                 Trypanosoma brucei. J Cell Biol 105: 2649&#226;&#8364;&#8220;2654. <br />     genome sequence Trypanosoma cruzi, etiologic agent Chagas disease.            53. Bangs JD, Uyetake L, Brickman MJ, Balber AE, Boothroyd JC (1993) Molecular <br />     Science 309: 409&#226;&#8364;&#8220;415.                                                                       cloning cellular localization BiP homologue Trypanosoma brucei. <br /> 31. El-Sayed NM, Myler PJ, Blandin G, Berriman M, Crabtree J, et al. (2005)                     Divergent ER retention signals lower eukaryote. J Cell Sci 105 (Pt 4): 1101&#226;&#8364;&#8220; <br />     Comparative genomics trypanosomatid parasitic protozoa. Science 309: 404&#226;&#8364;&#8220;                1113. <br />     409.                                                                                    54. CY, Ho HH, Malsam J, Chalouni C, West CM, et al <br /> </body></html>